SCHEMBL18049812

SCHEMBL18049812

CCC(=O)Oc1c(Br)ccc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ NCEH1 Q6PIU2 7/20 0.42
▸ LMNA P02545 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ ELANE P08246 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8210145 0.83 KMT2A (0.47) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL10440127 0.83 ALDH1A1 (0.56) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL30060732 0.82 NCEH1 (0.46) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL10793444 0.82 ALDH1A1 (0.44) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL11495787 0.81 ALDH1A1 (0.46) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL18032834 0.80 KMT2A (0.44) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL29372061 0.77 ELANE (0.50) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL20398449 0.77 ELANE (0.50) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL29369064 0.74 ELANE (0.39) ALDH1A1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL448000 0.73 ALDH1A1 (0.60) ALDH1A1KMT2ARAB9AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3268375-B1 PHOTOCHROMIC THIENOCHROMENE COMPOUNDS TRANSITIONS OPTICAL INC (US) 2022-06-15 — — EP disclosed
CN-107406459-B Photochromic thienobenzopyran compounds 光学转变公司 2021-06-08 — — CN disclosed
US-20180051037-A1 Photochromic Thienochromene Compounds TRANSITIONS OPTICAL, INC. 2018-02-22 — — US disclosed
EP-3268375-A1 PHOTOCHROMIC THIENOCHROMENE COMPOUNDS Transitions Optical, Inc. (US) 2018-01-17 — — EP disclosed
WO-2016144324-A1 PHOTOCHROMIC THIENOCHROMENE COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2016-09-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180051037-A1 Photochromic Thienochromene Compounds CRY1, CRY2, TERT ALDH1A1 59/4885KMT2A 1594/4885SMN1; SMN2 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback